Sergio Anastasi - Concepedia

Author

Sergio Anastasi

Institute of Cell Biology and Neurobiology

Also Known As

S Anastasi, S. Anastasi, Sergio Anastasi

Publications

921

Citations

H-Index

Concepts

All Affiliations

Institute of Cell Biology and Neurobiology Istituti di Ricovero e Cura a Carattere Scientifico Università degli studi di Cassino e del Lazio Meridionale Sapienza University of Rome Candiolo Cancer Institute

About

Sergio Anastasi is an author at Institute of Cell Biology and Neurobiology specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	371
2	Cell Biology	5	5	371
3	Health Sciences	2	2	52
4	Natural Sciences	1	1	80
5	Biochemistry	1	1	80

Sergio Anastasi

Publications

773

Citations

H-Index

Page 1

	Year	Citations
A Natural Hepatocyte Growth Factor/Scatter Factor Autocrine Loop in Myoblast Cells and the Effect of the Constitutive<i>Met</i>Kinase Activation on Myogenic Differentiation Sergio Anastasi, Silvia Giordano, Olga Sthandier, The Journal of Cell Biology	1997	173
A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation Yuri Frosi, Sergio Anastasi, Costanza Ballarò, The Journal of Cell Biology Kinase SuppressionSignaling PathwayCell RegulationReceptor Tyrosine KinaseAutophagy	2010	124
Feedback inhibition by RALT controls signal output by the ErbB network Sergio Anastasi, Loredana Fiorentino, Monia Fiorini, Oncogene Control MethodFeedback LoopErbb NetworkSignal OutputSignal Processing	2003	121
Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin Sergio Anastasi, Gianluca Sala, Huiping Chen, Oncogene Breast OncologyErbb-2 Oncogenic PotencyMedicineErbb2-amplified Breast CarcinomasImmunology	2005	116
The evolutionarily conserved EBR module of RALT/MIG6 mediates suppression of the EGFR catalytic activity Sergio Anastasi, Maria Francesca Baietti, Yuri Frosi, Oncogene Signal TransductionEbr ModuleBiochemistryNatural SciencesMolecular Biology	2007	80
FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma Giulia Cristinziano, Manuela Porru, Dante Lamberti, Journal of Hepatology HepatologyBiliary CancerHepatobiliary TumorPathologyOncogenic Transformation	2021	79
HSP90 Inhibition Drives Degradation of FGFR2 Fusion Proteins: Implications for Treatment of Cholangiocarcinoma Dante Lamberti, Giulia Cristinziano, Manuela Porru, Hepatology Hsp90 BlockadePathologyCholangiopathiesFgfr2 FusionsCancer Biology	2018	30
miR‐205 mediates adaptive resistance to <scp>MET</scp> inhibition via <scp>ERRFI</scp> 1 targeting and raised <scp>EGFR</scp> signaling Cristina Migliore, Elena Morando, Elena Ghiso, EMBO Molecular Medicine	2018	28
Hepatocyte growth factor stimulates cell motility in cultures of the striatal progenitor cells ST14A Emanuele Cacci, Monica Salani, Sergio Anastasi, Journal of Neuroscience Research Receptor MetCell CultureCell ProliferationCell GrowthCellular Physiology	2003	22

Page 1